PD-L1 regulates inflammatory programs of macrophages from human pluripotent stem cells.
Handi CaoYang XiangShihui ZhangYiming ChaoJilong GuoTheo AurichJoshua Wing-Kei HoYuanhua HuangPentao LiuRyohichi SugimuraPublished in: Life science alliance (2023)
Programmed death ligand 1 (PD-L1) serves as a pivotal immune checkpoint in both the innate and adaptive immune systems. PD-L1 is expressed in macrophages in response to IFNγ. We examined whether PD-L1 might regulate macrophage development. We established PD-L1 KO ( CD274 -/- ) human pluripotent stem cells and differentiated them into macrophages and observed a 60% reduction in CD11B + CD45 + macrophages in CD274 -/- ; this was orthogonally verified, with the PD-L1 inhibitor BMS-1166 reducing macrophages to the same fold. Single-cell RNA sequencing further confirmed the down-regulation of the macrophage-defining transcription factors SPI1 and MAFB Furthermore, CD274 -/- macrophages reduced the level of inflammatory signals such as NF-κB and TNF, and chemokine secretion of the CXCL and CCL families. Anti-inflammatory TGF-β was up-regulated. Finally, we identified that CD274 -/- macrophages significantly down-regulated interferon-stimulated genes despite the presence of IFNγ in the differentiation media. These data suggest that PD-L1 regulates inflammatory programs of macrophages from human pluripotent stem cells.
Keyphrases
- pluripotent stem cells
- single cell
- endothelial cells
- transcription factor
- immune response
- oxidative stress
- nk cells
- adipose tissue
- public health
- dendritic cells
- signaling pathway
- rheumatoid arthritis
- gene expression
- rna seq
- toll like receptor
- induced pluripotent stem cells
- high throughput
- inflammatory response
- dna binding
- artificial intelligence
- epithelial mesenchymal transition
- dna methylation
- transforming growth factor
- cell proliferation
- pi k akt
- genome wide identification